Byooviz Prices, Coupons, Copay Cards & Patient Assistance
Byooviz (ranibizumab ophthalmic) is a member of the anti-angiogenic ophthalmic agents drug class and is commonly used for Macular Degeneration, Macular Edema, Macular Edema Following Retinal Vein Occlusion, and others.
Byooviz prices
Intravitreal Solution
nuna 10 mg/mL Byooviz intravitreal solution from $1,252.49 for 0.05 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 0.05 milliliters | $25,049.80 | $1,252.49 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Byooviz Coupons, Copay Cards and Rebates
Byooviz offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Byooviz Drug Copay Program
Eligible commercially insured patients may pay lower copay costs under this program for their medication.
- Applies to:
- Byooviz
- Number of uses:
- Per prescription per year
Form more information phone: 877-422-8360 or Visit website
Byooviz Administration Copay Program
Eligible commercially insured patients may qualify for reduced copay costs for medication administration under this program, with an annual cap on assistance.
- Applies to:
- Byooviz
- Number of uses:
- Per prescription per year
Form more information phone: 877-422-8360 or Visit website
Patient Assistance & Copay Programs for Byooviz
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Byooviz (ranibizumab-nuna) Injection; Intravitreal
More information please phone: 866-316-7263 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Yesafili
Yesafili (aflibercept-jbvf) is an interchangeable biosimilar to Eylea that may be given by ...
More about Byooviz (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español